1
/
of
1
AntibodySystem
SKU:DVV03805-1MG
Research Grade Lesofavumab
Research Grade Lesofavumab
Regular price
$318.00 USD
Regular price
Sale price
$318.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Catalog No.: DVV03805
| Catalog No. | DVV03805 |
|---|---|
| Product name | Research Grade Lesofavumab |
| Size | 1 mg; 5 mg; 25 mg |
| Host species | Human |
| Species reactivity | Influenza B virus |
| Form | Liquid |
| Storage buffer | 0.01M PBS, pH 7.4. |
| Purity | >95% as determined by SDS-PAGE. |
| Clonality | Monoclonal |
| Isotype | IgG1, kappa |
| Applications | Research Grade Biosimilar |
| Target | HA/Hemagglutinin |
| Purification | Protein A/G purified from cell culture supernatant. |
| Endotoxin level | Please contact with the lab for this information. |
| Expression system | Mammalian Cells |
| Accession | P03461 |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. |
| Alternative Names | RG6024, RG 6024, MHAB5553A, RG70026, RO7045557, CAS: 1807960-57-1 |
| Clone ID | Lesofavumab |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Description | Lesofavumab is a Recombinant monoclonal antibody to Influenza B virus hemagglutinin. Lesofavumab is a human monoclonal antibody that can be potentially used in the treatment of Influenza B infection. Genentech, a subsidiary of Roche, is developing lesofavumab (RG 6024), a monoclonal antibody, for the treatment of influenza B infections. |
Share
